- The North America drug delivery devices market is currently experiencing significant expansion due to the increasing focus on personalized and targeted therapies, which are boosting demand for innovative delivery technologies
- Growth in outpatient care and rising adoption of patient-centric drug delivery solutions are shaping the market, as healthcare providers prioritize ease of use and improved patient compliance
- U.S. is expected to dominate the North America drug delivery devices market due to its strong healthcare infrastructure, high adoption rate of advanced drug delivery technologies, and the presence of key pharmaceutical and medical device manufacturers. The country's extensive research and development activities, along with robust regulatory frameworks, further bolster its leadership in the market.
- Canada is expected to be the fastest growing region in the North America drug delivery devices market during the forecast period due to the increasing prevalence of chronic diseases, a growing elderly population, and rising demand for more efficient drug delivery solutions. In addition, Canada's investment in healthcare innovation and technology adoption supports the rapid expansion of the drug delivery devices sector.
- The injectable drug delivery segment is expected to dominate the North America drug delivery devices market with the largest share of 64.8% in 2025 due to its growing use in the administration of biologics, vaccines, and chronic disease management, offering higher precision and faster therapeutic effects compared to other delivery methods.
